Target Details
| UniProt AC | P15056 |
|---|---|
| Gene Symbol | BRAF |
| Protein Name | Serine/threonine-protein kinase B-raf |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00130 (C1_1) PF07714 (PK_Tyr_Ser-Thr) PF02196 (RBD) |
Summary
- Multi-target molecules 2,643
- Clinical molecules 78
- Avg pChEMBL 7.81
KEGG Pathways (44)
- Acute myeloid leukemia
- Alcoholism
- Alzheimer disease
- Bladder cancer
- Breast cancer
- Chemical carcinogenesis - reactive oxygen species
- Chemokine signaling pathway
- Chronic myeloid leukemia
- Colorectal cancer
- Cushing syndrome
- EGFR tyrosine kinase inhibitor resistance
- Endocrine resistance
- Endometrial cancer
- ErbB signaling pathway
- Focal adhesion
- FoxO signaling pathway
- Gastric cancer
- Glioma
- Hepatitis B
- Hepatitis C
- Hepatocellular carcinoma
- Insulin signaling pathway
- Long-term depression
- Long-term potentiation
- MAPK signaling pathway
- Melanoma
- Natural killer cell mediated cytotoxicity
- Neurotrophin signaling pathway
- Non-small cell lung cancer
- Pancreatic cancer
- Parathyroid hormone synthesis, secretion and action
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Progesterone-mediated oocyte maturation
- Prostate cancer
- Proteoglycans in cancer
- Rap1 signaling pathway
- Regulation of actin cytoskeleton
- Renal cell carcinoma
- Serotonergic synapse
- Thyroid cancer
- Vascular smooth muscle contraction
- cAMP signaling pathway
- mTOR signaling pathway
Associated Diseases (10)
Active Molecules (2,643)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
WQOBMKLNZZRYPF
|
8.8 | IC50 | 2 | — | |
XLQXGWVZMIFIPR
|
8.8 | IC50 | 2 | — | |
XNYZWJDKGDUFBJ
|
8.8 | IC50 | 2 | — | |
YHCWAZKQQRNLLI
|
8.8 | IC50 | 2 | — | |
ZQVAYYPNZFAWMA
|
8.8 | IC50 | 2 | — | |
NRIIVZIVGFDQHT
|
8.8 | IC50 | 2 | — | |
OWLWCBXQZLBGRU
|
8.8 | IC50 | 2 | — | |
RGBVEWZJKRSQCA
|
8.8 | IC50 | 2 | — | |
VQVHBBKOZXGEBY
|
8.8 | IC50 | 2 | — | |
ZNVCVMODGVQVMO
|
8.8 | IC50 | 2 | — | |
CQLBJFSFGLKNEO
|
8.8 | IC50 | 2 | — | |
DAPUTCXAHDOMMA
|
8.8 | IC50 | 2 | — | |
FEJAQUKVYQVYED
|
8.8 | IC50 | 2 | — | |
IQDUYZHLQPWSGV
|
8.8 | IC50 | 2 | — | |
KAAVGAUVTMYYBL
|
8.8 | IC50 | 2 | — | |
MUGSHVQXVRLFFT
|
8.8 | IC50 | 2 | — | |
OJBDIEWQHBNHTP
|
8.8 | IC50 | 2 | — | |
SZEJLGPLCDEGEZ
|
8.8 | IC50 | 2 | — | |
WHNDCWPRICLPRA
|
8.8 | IC50 | 2 | — | |
YJAFXQYRMGBMNV
|
8.8 | IC50 | 2 | — | |
AHAVAGXJMSMGRE
|
8.8 | IC50 | 2 | — | |
FRNMUZNDLUBORX
|
8.8 | IC50 | 2 | — | |
IGWCLHKLZSDPMB
|
8.8 | IC50 | 2 | — | |
ZCLTTZZAFRHYQD
|
8.8 | IC50 | 2 | — | |
BYXXBDVYEKKNKK
|
8.8 | IC50 | 2 | — | |
FAFSJPCFIBDSIA
|
8.8 | IC50 | 2 | — | |
HSDDNNQIPLXBIA
|
8.8 | IC50 | 2 | — | |
HXMAODVOOCBYKA
|
8.8 | IC50 | 2 | — | |
IJGVWFVFWOQAPF
|
8.8 | IC50 | 2 | — | |
OJMHBRGTXHCAEY
|
8.8 | IC50 | 2 | — | |
PQOYWULWAJZHJZ
|
8.8 | IC50 | 2 | — | |
QMAKKWAGBXUGSO
|
8.8 | IC50 | 2 | — | |
QPZFRTPSKVFCBQ
|
8.8 | IC50 | 2 | — | |
SBIWEVAYLVTCSL
|
8.8 | IC50 | 2 | — | |
USDDJVQBULIBKZ
|
8.8 | IC50 | 2 | — | |
VQESRMRLARJHIC
|
8.8 | IC50 | 2 | — | |
WJDMYVBMQQULTP
|
8.8 | IC50 | 2 | — | |
XFHVGKYTPQEBHL
|
8.8 | IC50 | 2 | — | |
CJIKCAUEUGYYMV
|
8.8 | IC50 | 2 | — | |
HZEMIVICCSKEOU
|
8.8 | IC50 | 2 | — | |
JZVPNWVNWCDNRJ
|
8.8 | IC50 | 2 | — | |
SDIALWKFQDWRQM
|
8.8 | IC50 | 2 | — | |
BSUIIPUXGLKINZ
|
8.8 | IC50 | 2 | — | |
RMAWTLGYTCCDFL
|
8.8 | IC50 | 2 | — | |
YDYJBUHNTGURQT
|
8.8 | IC50 | 2 | — | |
AKCLRSIFAYFSML
|
8.8 | IC50 | 2 | — | |
BFOACAOHDXZAEA
|
8.8 | IC50 | 2 | — | |
BHSNGSBPODQPHU
|
8.8 | IC50 | 2 | — | |
DBCCYBRCXIDJHP
|
8.8 | IC50 | 2 | — | |
DJEJCPKGTQTKTH
|
8.8 | IC50 | 2 | — |